Rehabilitation of Reading Deficits in Subacute Stroke Using Functional Magnetic Resonance Imaging (fMRI) Neurofeedback and Motor Imagery

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The overall goal of this project is to advance a biologically-based approach to treatment of reading disorders after stroke, which will expand the limits of cognitive rehabilitation. Using a novel brain imaging technique, called real-time functional magnetic resonance imaging (fMRI) neurofeedback combined with right hand motor imagery, this project will re-instate brain activity in the left language-dominant hemisphere. Stroke patients will practice modulating their own brain activity using fMRI neurofeedback signal and will select the most effective mental strategies that help them maintain brain activation patterns associated with better reading recovery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: t
View:

• First-ever left-hemisphere stroke \< 3 months prior to study recruitment or healthy volunteer

• Age: 18 - 80 years old

• Fluent and literate in English prior to stroke

• Reading deficits, defined as \>3 errors on the Paragraphs test (subtests VIII, IX) of the Reading Comprehension Battery for Aphasia-2nd ed. (RCBA-2) in keeping with the healthy control accuracy criterion of 86-100% correct.

Locations
United States
New Jersey
Kessler Foundation
RECRUITING
West Orange
Time Frame
Start Date: 2023-04-03
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 28
Treatments
Experimental: Motor Imagery and Contingent Neurofeedback (NFB)
This group will receive real-time fMRI NFB on the bases of participant's own brain activity
Sham_comparator: Motor Imagery and Non-contingent Neurofeedback (NFB)
This group will receive group will receive fMRI NFB based on another participant's brain activity
Related Therapeutic Areas
Sponsors
Leads: Kessler Foundation

This content was sourced from clinicaltrials.gov